Neurocrine Biosciences added to STI Equity Trades Portfolio

As described in today’s edition of Smart Tech 50 Weekly Movers, we are adding Neurocrine Biosciences (NSDQ: NBIX) to the STI Equity Trades Portfolio with a buy limit of $46, and a stop loss of $36.

Stock Talk

Add New Comments

You must be logged in to post to Stock Talk OR create an account